| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/30/2006 | EP1695982A1 Glycosylation-deficient hepatocyte growth factor |
| 08/30/2006 | EP1695980A2 Human papillomavirus E2 transactivation domain / inhibitor co-crystal and x-ray coordinates defining the inhibitor-binding pocket |
| 08/30/2006 | EP1695979A2 Gapped 2' modified oligonucleotides |
| 08/30/2006 | EP1695978A1 Nucleic acid ligands |
| 08/30/2006 | EP1695715A1 Vaccine compositions which are used to control amoebiasis and which are based on the 112kda surface protein from entamoeba histolytica |
| 08/30/2006 | EP1695091A2 Diagnostic and therapeutic use of the human hif3alpha gene and proteins for neurodegenerative diseases |
| 08/30/2006 | EP1695061A2 Method for treating neurological disorders |
| 08/30/2006 | EP1694864A2 Compositions and methods for the diagnosis and treatment of tumor |
| 08/30/2006 | EP1694861A2 Nucleic acid probes, broad-range primers, and methods in which they are used |
| 08/30/2006 | EP1694854A2 Novel carotenoids ketolases |
| 08/30/2006 | EP1694852A2 Mutant herpes simplex virus and use thereof in the treatment of squamous cell cancer |
| 08/30/2006 | EP1694851A2 Viral vectors controlled by a gene switch |
| 08/30/2006 | EP1694850A2 Plasmid system for multigene expression |
| 08/30/2006 | EP1694849A2 Plants having modified growth characteristics and method for making the same |
| 08/30/2006 | EP1694848A1 Novel chimeric plasminogen activators and their pharmaceutical use |
| 08/30/2006 | EP1694847A2 Serine proteases, nucleic acids encoding serine enzymes and vectors and host cells incorporating same |
| 08/30/2006 | EP1694846A1 A cell with improved secretion mediated by mrga protein or homologue |
| 08/30/2006 | EP1694845A1 Anticarcinoma antibidies and uses thereof |
| 08/30/2006 | EP1694844A2 Methods for producing olfactory gpcrs |
| 08/30/2006 | EP1694843A1 Rnai potency prediction method |
| 08/30/2006 | EP1694842A1 Rna amidates and thioamidates for rnai |
| 08/30/2006 | EP1694841A2 Cancer treatment |
| 08/30/2006 | EP1694840A2 Combination therapy associating a tgf-beta antagonist with a chemotherapeutic agent |
| 08/30/2006 | EP1694839A2 Laminin-5 modulators and uses thereof |
| 08/30/2006 | EP1694838A2 RNA INTERFERENCE MEDIATED INHIBITION OF GPRA AND AAA1 GENE EXPRESSION USING SHORT NUCLEIC ACID (siNA) |
| 08/30/2006 | EP1694837A1 Method |
| 08/30/2006 | EP1694833A1 2-methyl-6-solanylbenzoquinone methyltransferase as target for herbicides |
| 08/30/2006 | EP1694832A2 Cloning of cytochrome p450 genes from nicotiana |
| 08/30/2006 | EP1694830A2 Novel atypical pneumonia-causing virus |
| 08/30/2006 | EP1694825A2 Methods of generating stem cells and embryonic bodies carrying disease-causing mutations and methods of using same for studying genetic disorders |
| 08/30/2006 | EP1694823A2 Compositions and methods of use for a fibroblast growth factor |
| 08/30/2006 | EP1694706A2 Modified anti-cd52 antibody |
| 08/30/2006 | EP1694701A2 Pp2a/bgamma subunits, modulators thereof, and their uses in the treatment of mental disorders |
| 08/30/2006 | EP1694699A1 Yeast strains with improved fructose fermentation capacity |
| 08/30/2006 | EP1694698A1 Lawsonia intracellularis 26 kd subunit vaccine |
| 08/30/2006 | EP1694697A2 Surface-located campylobacter jejuni polypeptides |
| 08/30/2006 | EP1694696A1 Delivery peptides ,their constructs with active agents and use |
| 08/30/2006 | EP1694694A2 Replication competent hepatitis c virus and methods of use |
| 08/30/2006 | EP1694693A2 Methods for synthesis of encoded libraries |
| 08/30/2006 | EP1694692A1 Formulations and methods for denaturing proteins |
| 08/30/2006 | EP1694666A2 Novel spliced 5-ht1a receptors and methods, kits, and uses relating thereto |
| 08/30/2006 | EP1694364A2 System for treating and preventing breast cancer |
| 08/30/2006 | EP1694361A2 Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells |
| 08/30/2006 | EP1694350A1 Use of caspase-8 inhibitors for modulating hematopoiesis |
| 08/30/2006 | EP1644502A4 Materials and methods for the modulation of cyclin-dependent kinase inhibitor-like polypeptides in maize |
| 08/30/2006 | EP1576165A4 Methods for increasing total oil levels in plants |
| 08/30/2006 | EP1576094A4 Methods of creating modified promoters resulting in varying levels of gene expression |
| 08/30/2006 | EP1573322A4 METHODS OF SCREENING FOR TRPM4b MODULATORS |
| 08/30/2006 | EP1572880A4 Defensin polynucleotides and methods of use |
| 08/30/2006 | EP1571899A4 Organogenic transformation and regeneration |
| 08/30/2006 | EP1558745A4 Mutagenesis methods using ribavirin and/or rna replicases |
| 08/30/2006 | EP1551966A4 Methods for using artificial polynucleotides and compositions thereof to reduce transgene silencing |
| 08/30/2006 | EP1546383A4 Isolation of genetic molecules from a complex biological construct for use in genetic expression analysis |
| 08/30/2006 | EP1539970A4 Seed-associated promoter sequences |
| 08/30/2006 | EP1532247A4 Corn event pv-zmir13 (mon863) plants and compositions and methods for detection thereof |
| 08/30/2006 | EP1530581A4 Polymeric label molecules |
| 08/30/2006 | EP1504127B1 Amplification-hybridisation method for detecting and typing human papillomavirus |
| 08/30/2006 | EP1501350A4 Activation of equine oocytes |
| 08/30/2006 | EP1497444A4 Methods for increasing polypeptide production |
| 08/30/2006 | EP1485128A4 Nanostructures containing antibody assembly units |
| 08/30/2006 | EP1479773B1 Mite galectin |
| 08/30/2006 | EP1434872A4 Bbc3 gene promoter and methods for identifying modulators of apoptosis and bbc3 gene expression using a bbc3 gene promoter |
| 08/30/2006 | EP1423524B1 Method of protein production in plants |
| 08/30/2006 | EP1421198A4 Cell-based high-throughput screening methods |
| 08/30/2006 | EP1375668B1 Vegetative growth-specific promoter and genetically modified plants obtained thereby |
| 08/30/2006 | EP1334188B1 Cd19-specific redirected immune cells |
| 08/30/2006 | EP1294945B1 Method for detecting cytosine methylations |
| 08/30/2006 | EP1294898B1 FATTY ACID ELONGASE 3-KETOACYL CoA SYNTHASE POLYPEPTIDES |
| 08/30/2006 | EP1266015B1 Ecdysone receptor-based inducible gene expression system |
| 08/30/2006 | EP1266008B1 Acute neuronal induced calcium binding protein type 1 ligand |
| 08/30/2006 | EP1254260B1 Methods for diagnosing and treating heart disease |
| 08/30/2006 | EP1248844B1 Analogs of human basic fibroblast growth factor |
| 08/30/2006 | EP1230343B1 Aspegillus niger beta-glucosidase gene, protein and uses thereof |
| 08/30/2006 | EP1220602B1 Transgenic fiber producing plants with increased expression of sucrose phosphate synthase |
| 08/30/2006 | EP1210430B1 Muc-1 derived peptides |
| 08/30/2006 | EP1180524B1 Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides |
| 08/30/2006 | EP1171604B1 Dna sequence and recombinant production of a graminae allergen |
| 08/30/2006 | EP1151088B1 Improved phytases |
| 08/30/2006 | EP1133558B1 Compositions and methods for increasing bone mineralization |
| 08/30/2006 | EP1124979B1 Production of 3-hydroxypropionic acid in recombinant organisms |
| 08/30/2006 | EP1109913B1 Nucleotide sequences which code for the opca gene |
| 08/30/2006 | EP1098971B1 Myotilin, an actin-organizing protein |
| 08/30/2006 | EP1066042B1 Steroidal saponins for treating alzheimer's disease |
| 08/30/2006 | EP1037900A4 Kcnq2 and kcnq3-potassium channel genes which are mutated in benign familial neonatal convulsions (bfnc) and other epilepsies |
| 08/30/2006 | EP1036174B1 Novel peptide, apoep1.b, compositions and uses thereof |
| 08/30/2006 | EP1015596B1 Fusion proteins comprising hiv-1 tat and/or nef proteins |
| 08/30/2006 | EP1000146B1 5'ESTs FOR NON TISSUE SPECIFIC SECRETED PROTEINS |
| 08/30/2006 | EP0972036B1 Prion propagation inhibition by dominant-negative prion protein mutants |
| 08/30/2006 | EP0959128B1 Enzyme endoglucanase and cellulase preparations containing the same |
| 08/30/2006 | EP0934338B1 Cellular internalization of pigr stalk and associated ligands |
| 08/30/2006 | EP0910643B1 Ribonuclease resistant rna preparation and utilization |
| 08/30/2006 | EP0909316B1 Glial cell line-derived neurotrophic factor receptor |
| 08/30/2006 | EP0797674B1 Microspore-specific regulatory element |
| 08/30/2006 | EP0796104B1 Delivery of nucleic acid molecules to mucosal tissue |
| 08/30/2006 | EP0755450B1 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE |
| 08/30/2006 | EP0728200B1 Haemophilus transferrin receptor genes |
| 08/30/2006 | EP0531498B1 Production of plants resistant to attacks of sclerotinia sclerotiorum by introducing a gene coding for an oxalate oxidase |
| 08/30/2006 | EP0529033B1 Nucleotide sequences coding for alpha chain variable regions in human lymphocyte receptors and applications thereof |
| 08/30/2006 | CN1826519A Bioassay substrate and bioassay device and method |
| 08/30/2006 | CN1826414A Mutant adeno-associated virus virions and methods of use thereof |